Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
153.9 INR | -0.12% | +5.50% | +10.85% |
May. 14 | Jefferies Adjusts Piramal Pharma’s Price Target to INR180 From INR170, Keeps at Buy | MT |
May. 13 | Transcript : Piramal Pharma Limited, Q4 2024 Earnings Call, May 13, 2024 |
Business Summary
Number of employees: 6,295
Sales per Business
INR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Global Pharma
87.0
%
| 22,356 | 72.2 % | 61,581 | 87.0 % | +175.45% |
Over the Counter Products
11.6
%
| 7,420 | 24.0 % | 8,188 | 11.6 % | +10.35% |
Distribution Fees
0.8
%
| - | - | 556 | 0.8 % | - |
Scrap
0.5
%
| - | - | 323 | 0.5 % | - |
Others
0.2
%
| - | - | 169 | 0.2 % | - |
Sales per region
INR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
International
79.6
%
| - | - | 56,371 | 79.6 % | - |
India
20.4
%
| 30,950 | 100.0 % | 14,445 | 20.4 % | -53.33% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Peter DeYoung
CEO | Chief Executive Officer | 46 | 20-03-03 |
Vivek Valsaraj
PSD | President | 51 | 20-06-09 |
Vinay Agrawal
COO | Chief Operating Officer | 60 | 20-04-04 |
Gagan Borana
IRC | Investor Relations Contact | - | - |
Prasanth M. S.
SAM | Sales & Marketing | 51 | 20-06-09 |
Vikram Duggal
HRO | Human Resources Officer | 50 | 20-01-07 |
Sameer Penkar
SAM | Sales & Marketing | - | 20-06-09 |
Corporate Secretary | - | 20-03-03 | |
Rashida Najmi
PRN | Corporate Officer/Principal | 58 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 43 | 21-01-03 | |
Neeraj Bharadwaj
BRD | Director/Board Member | 55 | - |
Director/Board Member | 76 | 21-02-08 | |
Director/Board Member | 51 | 22-03-29 | |
Vibha Paul Rishi
BRD | Director/Board Member | 64 | 22-09-28 |
Director/Board Member | 65 | 21-02-08 | |
Peter DeYoung
CEO | Chief Executive Officer | 46 | 20-03-03 |
Vivek Valsaraj
PSD | President | 51 | 20-06-09 |
Peter Stevenson
BRD | Director/Board Member | - | 22-03-29 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,320,816,324 | 354,235,407 ( 26.82 %) | 0 | 26.82 % |
Company contact information
Piramal Pharma Ltd.
507, Skyline Wealth Space, 5th Floor C2 Wing, Skyline Oasis Complex
400086, Mumbai
+91 22 3802 3000
http://www.piramal.com/businesses/piramal-pharma/Sector
Sales per Business
Sales per region
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+10.85% | 2.44B | |
+48.53% | 780B | |
+41.76% | 627B | |
-6.37% | 353B | |
+20.93% | 334B | |
+8.21% | 296B | |
+18.09% | 244B | |
-0.86% | 217B | |
+11.49% | 214B | |
+4.40% | 161B |
- Stock Market
- Equities
- PPLPHARMA Stock
- Company Piramal Pharma Limited